Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
8.35M
-
Number of holders
-
4
-
Total 13F shares, excl. options
-
10.3K
-
Shares change
-
+10.3K
-
Total reported value, excl. options
-
$38.7K
-
Value change
-
+$38.7K
-
Number of buys
-
4
-
Price
-
$3.76
Significant Holders of ZyVersa Therapeutics, Inc. - Common Stock, $0.0001 par value per share (ZVSA) as of Q2 2024
4 filings reported holding ZVSA - ZyVersa Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q2 2024.
ZyVersa Therapeutics, Inc. - Common Stock, $0.0001 par value per share (ZVSA) has 4 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.3K shares
of 8.35M outstanding shares and own 0.12% of the company stock.
Largest 4 shareholders include ADAR1 Capital Management, LLC (9.6K shares), Tower Research Capital LLC (TRC) (699 shares), BANK OF AMERICA CORP /DE/ (7 shares), and JPMORGAN CHASE & CO (1 shares).
This table shows the top 4 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.